From Strategic Partnering to Orchestrated Partnering: Navigating the Next Era of Precision Medicine

• The next breakthrough in precision medicine may not come from a new biomarker or a new diagnostic technology. It may come from how effectively organizations coordinate them
• As companion diagnostics evolve into broader ecosystems spanning AI, liquid biopsy, MRD, digital pathology, and real-world evidence, traditional partnering approaches are being tested in new ways. As complexity increases, partnering must evolve
• This session explores how J&J is adapting to increasing complexity and what the future of collaboration may look like across pharma, biotech, and diagnostics

Speakers:

Viraj Tyagi

Global Alliance Leader, Strategic Partnering, Precision Medicine & Diagnostics

Johnson & Johnson Innovative Medicine